5/10/2013

Prophylactic platelet transfusions lowered the risk of significant bleeding events in patients with blood cancers, according to a study in the New England Journal of Medicine. There was a 7% decrease in the proportion of bleeding events among patients who received platelets. "The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding," researchers concluded.

Related Summaries